Abstract

The pharmacological effects of limonene, especially their derivatives, are currently at the forefront of research for drug development and discovery as well and structure-based drug design using huge chemical libraries are already widespread in the early stages of therapeutic and drug development. Here, various limonene derivatives are studied computationally for their potential utilization against the capsid protein of Herpes Simplex Virus-1. Firstly, limonene derivatives were designed by structural modification followed by conducting a molecular docking experiment against the capsid protein of Herpes Simplex Virus-1. In this research, the obtained molecular docking score exhibited better efficiency against the capsid protein of Herpes Simplex Virus-1 and hence we conducted further in silico investigation including molecular dynamic simulation, quantum calculation, and ADMET analysis. Molecular docking experiment has documented that Ligands 02 and 03 had much better binding affinities (− 7.4 kcal/mol and − 7.1 kcal/mol) to capsid protein of Herpes Simplex Virus-1 than Standard Acyclovir (− 6.5 kcal/mol). Upon further investigation, the binding affinities of primary limonene were observed to be slightly poor. But including the various functional groups also increases the affinities and capacity to prevent viral infection of the capsid protein of Herpes Simplex Virus-1. Then, the molecular dynamic simulation confirmed that the mentioned ligands might be stable during the formation of drug-protein complexes. Finally, the analysis of ADMET was essential in establishing them as safe and human-useable prospective chemicals. According to the present findings, limonene derivatives might be a promising candidate against the capsid protein of Herpes Simplex Virus-1 which ultimately inhibits Herpes Simplex Virus-induced encephalitis that causes interventions in brain inflammation. Our findings suggested further experimental screening to determine their practical value and utility.

Details

Title
Ligand-based drug design against Herpes Simplex Virus-1 capsid protein by modification of limonene through in silico approaches
Author
Islam, Md. Rezaul 1 ; Islam Sovon, Md. Shafiqul 2 ; Amena, Ummy 3 ; Rahman, Miadur 4 ; Hosen, Md. Eram 5 ; Kumer, Ajoy 6 ; Bourhia, Mohammed 7 ; Bin Jardan, Yousef A. 8 ; Ibenmoussa, Samir 9 ; Wondmie, Gezahign Fentahun 10 

 Daffodil International University, Department of Pharmacy, Faculty of Allied Health Sciences, Dhaka, Bangladesh (GRID:grid.442989.a) (ISNI:0000 0001 2226 6721) 
 University of Dhaka, Department of Pharmacy, Faculty of Pharmacy, Dhaka, Bangladesh (GRID:grid.8198.8) (ISNI:0000 0001 1498 6059) 
 Jagannath University, Department of Pharmacy, Faculty of Life & Earth Sciences, Dhaka, Bangladesh (GRID:grid.443016.4) (ISNI:0000 0004 4684 0582) 
 North South University, Department of Pharmaceutical Sciences, Dhaka, Bangladesh (GRID:grid.443020.1) (ISNI:0000 0001 2295 3329) 
 University of Rajshahi, Department of Genetic Engineering and Biotechnology, Rajshahi, Bangladesh (GRID:grid.412656.2) (ISNI:0000 0004 0451 7306) 
 International University of Business Agriculture and Technology (IUBAT), Department of Chemistry, College of Arts and Sciences, Dhaka, Bangladesh (GRID:grid.443015.7) (ISNI:0000 0001 2222 8047); Saveetha Institute of Medical and Technical Sciences in Saveetha Medical College and Hospital, Center for Global Health Research, Chennai, India (GRID:grid.412431.1) (ISNI:0000 0004 0444 045X) 
 Ibn Zohr University, Laboratory of Biotechnology and Natural Resources Valorization, Faculty of Sciences, Agadir, Morocco (GRID:grid.417651.0) (ISNI:0000 0001 2156 6183) 
 King Saud University, Department of Pharmaceutics, College of Pharmacy, Riyadh, Saudi Arabia (GRID:grid.56302.32) (ISNI:0000 0004 1773 5396) 
 University of Montpellier, Laboratory of Therapeutic and Organic Chemistry, Faculty of Pharmacy, Montpellier, France (GRID:grid.121334.6) (ISNI:0000 0001 2097 0141) 
10  Bahir Dar University, Department of Biology, Bahir Dar, Ethiopia (GRID:grid.442845.b) (ISNI:0000 0004 0439 5951) 
Pages
9828
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3048261500
Copyright
© The Author(s) 2024. corrected publication 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.